Loading…
A Practical Approach to Quantitative Grayscale Ultrasound Analysis of Hepatic Steatosis in Pediatric Patients Using a Picture Archiving and Communication System–Based Tool
Objectives To evaluate the efficacy of a picture archiving and communication system (PACS)‐based ultrasound (US) quantification technique for diagnosis of hepatic steatosis in a pediatric population. Methods Abdominal US images of 49 pediatric patients (≤18 years) with histopathologically proven dia...
Saved in:
Published in: | Journal of ultrasound in medicine 2018-10, Vol.37 (10), p.2395-2403 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Objectives
To evaluate the efficacy of a picture archiving and communication system (PACS)‐based ultrasound (US) quantification technique for diagnosis of hepatic steatosis in a pediatric population.
Methods
Abdominal US images of 49 pediatric patients (≤18 years) with histopathologically proven diagnoses of hepatic steatosis (n = 17), nonsteatotic liver disease (n = 19), and a normal liver (n = 13) were retrospectively reviewed. Patient demographics, the fibrosis stage, and the steatosis grade were obtained from the database. Quantitative grayscale measurements of the echo intensity level of the liver and kidneys were performed on the US images using the PACS measuring tool. The hepatorenal ratio was obtained by dividing mean liver by mean kidney values. The heterogeneity index for the liver was calculated by dividing the liver standard deviation by mean liver values. Hepatorenal ratio and heterogeneity index values of the 3 groups were correlated with pathologic results and compared by a 1‐way analysis of variance. A receiver operating characteristic curve analysis was performed, and cutoff values were determined.
Results
The hepatorenal ratio of the hepatic steatosis group was significantly greater than those of the control and nonsteatotic liver disease groups (P |
---|---|
ISSN: | 0278-4297 1550-9613 |
DOI: | 10.1002/jum.14598 |